Investigating how Bach1 affects neuroprotection in Alzheimer's disease
Neuroprotective mechanisms of Bach1-Derepression in Alzheimer’s Disease
This study is looking at a protein called Bach1 to see if blocking it can help another protein, Nrf2, protect brain cells in people with Alzheimer's disease, with the hope of finding new ways to slow down memory loss.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical University of South Carolina NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-10434394 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of a protein called Bach1 in Alzheimer's disease, which is a progressive condition that leads to memory loss. The study aims to explore how inhibiting Bach1 can activate another protein, Nrf2, that may help protect brain cells from damage. By examining the mechanisms involved, the researchers hope to identify safe and effective ways to enhance Nrf2 activity, potentially leading to new treatments for Alzheimer's. Patients may benefit from insights gained into therapeutic strategies that could slow down or alter the disease's progression.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that protect brain cells and slow the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in targeting Nrf2 pathways for neuroprotection, suggesting that this approach could be beneficial.
Where this research is happening
Charleston, United States
- Medical University of South Carolina — Charleston, United States (Active)
Researchers
- Principal investigator: Thomas, Bobby — Medical University of South Carolina
- Study coordinator: Thomas, Bobby
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.